1CG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CRISPR Therapeutics AG

Watchlist Manager

Watchlist

Price: 45.735 EUR -1.55%

Market Cap: €5.6B

C	CRISPR Therapeutics AG SWB:1CG	CH
M	Mahindra and Mahindra Ltd LSE:MHID	IN
D	Diana Shipping Inc XHAM:DSZ	GR
I	Instalco AB F:4II	SE
M	MetLife Inc XBER:MWZ	US
S	Sugi Holdings Co Ltd OTC:SGIPF	JP
M	Meta Platforms Inc XBER:FB2A	US
	Jack Henry & Associates Inc NASDAQ:JKHY	US
P	Pearson PLC XBER:PES	UK
W	WPP PLC F:0WP	UK
C	CF Industries Holdings Inc LSE:0HQU	US
V	Vodafone Group PLC OTC:VODPF	UK
T	Ta Liang Technology Co Ltd TWSE:3167	TW
	Truworths International Ltd F:IUE	ZA
	Borosil Renewables Ltd NSE:BORORENEW	IN

Profitability Summary

CRISPR Therapeutics AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-15 754%

Negative 3Y Average Operating Margin

-3 162%

Declining Operating Margin

-560% > -15 754%

Negative Net Margin

-13 857%

Negative 3Y Average Net Margin

-2 980%

Declining Net Margin

-522% > -13 857%

Negative Free Cash Flow Margin

-10 387%

Negative 3Y Average Free Cash Flow Margin

-2 051%

Declining Free Cash Flow Margin

-375% > -10 387%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-131%

Declining ROIC

-166% > -229%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.